Table of Contents January 13, 2005; Volume Issue 1 suppl Clinical Practice of Molecular Radiotherapy - Steven M. Larson and Eric P. Krenning, Guest Editors
A
Adelstein, S. James
- You have accessRadiobiologic Principles in Radionuclide TherapyAmin I. Kassis and S. James AdelsteinJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 4S-12S;
Anthony, Lowell B.
- You have accessOverview of Results of Peptide Receptor Radionuclide Therapy with 3 Radiolabeled Somatostatin AnalogsDik J. Kwekkeboom, Jan Mueller-Brand, Giovanni Paganelli, Lowell B. Anthony, Stanislas Pauwels, Larry K. Kvols, Thomas M. O’Dorisio, Roelf Valkema, Lisa Bodei, Marco Chinol, Helmut R. Maecke and Eric P. KrenningJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 62S-66S;
B
Bakker, Willem H.
- You have accessPeptide Receptor Radionuclide Therapy for Non-Radioiodine-Avid Differentiated Thyroid CarcinomaJaap J.M. Teunissen, Dik J. Kwekkeboom, Peter P.M. Kooij, Willem H. Bakker and Eric P. KrenningJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 107S-114S;
- You have accessLong-Term Follow-Up of Renal Function After Peptide Receptor Radiation Therapy with 90Y-DOTA0,Tyr3-Octreotide and 177Lu-DOTA0, Tyr3-OctreotateRoelf Valkema, Stanislas A. Pauwels, Larry K. Kvols, Dik J. Kwekkeboom, Francois Jamar, Marion de Jong, Raffaella Barone, Stephan Walrand, Peter P.M. Kooij, Willem H. Bakker, Janet Lasher and Eric P. KrenningJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 83S-91S;
Barone, Raffaella
- You have accessLong-Term Follow-Up of Renal Function After Peptide Receptor Radiation Therapy with 90Y-DOTA0,Tyr3-Octreotide and 177Lu-DOTA0, Tyr3-OctreotateRoelf Valkema, Stanislas A. Pauwels, Larry K. Kvols, Dik J. Kwekkeboom, Francois Jamar, Marion de Jong, Raffaella Barone, Stephan Walrand, Peter P.M. Kooij, Willem H. Bakker, Janet Lasher and Eric P. KrenningJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 83S-91S;
- You have accessPractical Dosimetry of Peptide Receptor Radionuclide Therapy with 90Y-Labeled Somatostatin AnalogsStanislas Pauwels, Raffaella Barone, Stéphan Walrand, Françoise Borson-Chazot, Roelf Valkema, Larry K. Kvols, Eric P. Krenning and François JamarJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 92S-98S;
- You have accessPatient-Specific Dosimetry in Predicting Renal Toxicity with 90Y-DOTATOC: Relevance of Kidney Volume and Dose Rate in Finding a Dose–Effect RelationshipRaffaella Barone, Françoise Borson-Chazot, Roelf Valkema, Stéphan Walrand, Franck Chauvin, Lida Gogou, Larry K. Kvols, Eric P. Krenning, François Jamar and Stanislas PauwelsJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 99S-106S;
Bernard, Bert F.
- You have accessCombination Radionuclide Therapy Using 177Lu- and 90Y-Labeled Somatostatin AnalogsMarion de Jong, Wout A.P. Breeman, Roelf Valkema, Bert F. Bernard and Eric P. KrenningJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 13S-17S;
Bodei, Lisa
- You have accessOverview of Results of Peptide Receptor Radionuclide Therapy with 3 Radiolabeled Somatostatin AnalogsDik J. Kwekkeboom, Jan Mueller-Brand, Giovanni Paganelli, Lowell B. Anthony, Stanislas Pauwels, Larry K. Kvols, Thomas M. O’Dorisio, Roelf Valkema, Lisa Bodei, Marco Chinol, Helmut R. Maecke and Eric P. KrenningJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 62S-66S;
Borson-Chazot, Françoise
- You have accessPractical Dosimetry of Peptide Receptor Radionuclide Therapy with 90Y-Labeled Somatostatin AnalogsStanislas Pauwels, Raffaella Barone, Stéphan Walrand, Françoise Borson-Chazot, Roelf Valkema, Larry K. Kvols, Eric P. Krenning and François JamarJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 92S-98S;
- You have accessPatient-Specific Dosimetry in Predicting Renal Toxicity with 90Y-DOTATOC: Relevance of Kidney Volume and Dose Rate in Finding a Dose–Effect RelationshipRaffaella Barone, Françoise Borson-Chazot, Roelf Valkema, Stéphan Walrand, Franck Chauvin, Lida Gogou, Larry K. Kvols, Eric P. Krenning, François Jamar and Stanislas PauwelsJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 99S-106S;
Breeman, Wout A.P.
- You have accessCombination Radionuclide Therapy Using 177Lu- and 90Y-Labeled Somatostatin AnalogsMarion de Jong, Wout A.P. Breeman, Roelf Valkema, Bert F. Bernard and Eric P. KrenningJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 13S-17S;
Buchsbaum, Donald J.
- You have accessRadiotargeted Gene TherapyDonald J. Buchsbaum, Tandra R. Chaudhuri and Kurt R. ZinnJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 179S-186S;
C
Capello, Astrid
- You have accessInduction of Apoptosis with Hybrids of Arg-Gly-Asp Molecules and Peptides and Antimitotic Effects of Hybrids of Cytostatic Drugs and PeptidesLeo J. Hofland, Astrid Capello, Eric P. Krenning, Marion de Jong and Martin P. van HagenJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 191S-198S;
Chaudhuri, Tandra R.
- You have accessRadiotargeted Gene TherapyDonald J. Buchsbaum, Tandra R. Chaudhuri and Kurt R. ZinnJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 179S-186S;
Chauvin, Franck
- You have accessPatient-Specific Dosimetry in Predicting Renal Toxicity with 90Y-DOTATOC: Relevance of Kidney Volume and Dose Rate in Finding a Dose–Effect RelationshipRaffaella Barone, Françoise Borson-Chazot, Roelf Valkema, Stéphan Walrand, Franck Chauvin, Lida Gogou, Larry K. Kvols, Eric P. Krenning, François Jamar and Stanislas PauwelsJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 99S-106S;
Cheung, Nai-Kong V.
- You have accessAntibody-Based Targeted Radiation to Pediatric TumorsShakeel Modak and Nai-Kong V. CheungJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 157S-163S;
Chinol, Marco
- You have accessOverview of Results of Peptide Receptor Radionuclide Therapy with 3 Radiolabeled Somatostatin AnalogsDik J. Kwekkeboom, Jan Mueller-Brand, Giovanni Paganelli, Lowell B. Anthony, Stanislas Pauwels, Larry K. Kvols, Thomas M. O’Dorisio, Roelf Valkema, Lisa Bodei, Marco Chinol, Helmut R. Maecke and Eric P. KrenningJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 62S-66S;
D
de Herder, Wouter W.
- You have accessMolecular Imaging as In Vivo Molecular Pathology for Gastroenteropancreatic Neuroendocrine Tumors: Implications for Follow-Up After TherapyEric P. Krenning, Roelf Valkema, Dik J. Kwekkeboom, Wouter W. de Herder, Casper H.J. van Eijck, Marion de Jong, Stanislas Pauwels and Jean-Claude ReubiJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 76S-82S;
de Jong, Marion
- You have accessCombination Radionuclide Therapy Using 177Lu- and 90Y-Labeled Somatostatin AnalogsMarion de Jong, Wout A.P. Breeman, Roelf Valkema, Bert F. Bernard and Eric P. KrenningJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 13S-17S;
- You have accessInduction of Apoptosis with Hybrids of Arg-Gly-Asp Molecules and Peptides and Antimitotic Effects of Hybrids of Cytostatic Drugs and PeptidesLeo J. Hofland, Astrid Capello, Eric P. Krenning, Marion de Jong and Martin P. van HagenJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 191S-198S;
- You have accessMolecular Imaging as In Vivo Molecular Pathology for Gastroenteropancreatic Neuroendocrine Tumors: Implications for Follow-Up After TherapyEric P. Krenning, Roelf Valkema, Dik J. Kwekkeboom, Wouter W. de Herder, Casper H.J. van Eijck, Marion de Jong, Stanislas Pauwels and Jean-Claude ReubiJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 76S-82S;
- You have accessLong-Term Follow-Up of Renal Function After Peptide Receptor Radiation Therapy with 90Y-DOTA0,Tyr3-Octreotide and 177Lu-DOTA0, Tyr3-OctreotateRoelf Valkema, Stanislas A. Pauwels, Larry K. Kvols, Dik J. Kwekkeboom, Francois Jamar, Marion de Jong, Raffaella Barone, Stephan Walrand, Peter P.M. Kooij, Willem H. Bakker, Janet Lasher and Eric P. KrenningJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 83S-91S;
Divgi, Chaitanya
- You have accessCurrent Status of Therapy of Solid TumorsYuliya S. Jhanwar and Chaitanya DivgiJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 141S-150S;
F
Farahati, Jamshid
- You have accessRadiosynovectomy in Rheumatology, Orthopedics, and HemophiliaPeter Schneider, Jamshid Farahati and Christoph ReinersJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 48S-54S;
G
Gogou, Lida
- You have accessPatient-Specific Dosimetry in Predicting Renal Toxicity with 90Y-DOTATOC: Relevance of Kidney Volume and Dose Rate in Finding a Dose–Effect RelationshipRaffaella Barone, Françoise Borson-Chazot, Roelf Valkema, Stéphan Walrand, Franck Chauvin, Lida Gogou, Larry K. Kvols, Eric P. Krenning, François Jamar and Stanislas PauwelsJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 99S-106S;
Goldenberg, David M.
- You have accessPerspectives on Cancer Therapy with Radiolabeled Monoclonal AntibodiesRobert M. Sharkey and David M. GoldenbergJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 115S-127S;
H
Haberkorn, Uwe
- You have access68Ga-Labeled Peptides in Tumor ImagingHelmut R. Maecke, Michael Hofmann and Uwe HaberkornJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 172S-178S;
Hofland, Leo J.
- You have accessInduction of Apoptosis with Hybrids of Arg-Gly-Asp Molecules and Peptides and Antimitotic Effects of Hybrids of Cytostatic Drugs and PeptidesLeo J. Hofland, Astrid Capello, Eric P. Krenning, Marion de Jong and Martin P. van HagenJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 191S-198S;
Hofmann, Michael
- You have access68Ga-Labeled Peptides in Tumor ImagingHelmut R. Maecke, Michael Hofmann and Uwe HaberkornJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 172S-178S;
J
Jamar, Francois
- You have accessLong-Term Follow-Up of Renal Function After Peptide Receptor Radiation Therapy with 90Y-DOTA0,Tyr3-Octreotide and 177Lu-DOTA0, Tyr3-OctreotateRoelf Valkema, Stanislas A. Pauwels, Larry K. Kvols, Dik J. Kwekkeboom, Francois Jamar, Marion de Jong, Raffaella Barone, Stephan Walrand, Peter P.M. Kooij, Willem H. Bakker, Janet Lasher and Eric P. KrenningJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 83S-91S;
Jamar, François
- You have accessPractical Dosimetry of Peptide Receptor Radionuclide Therapy with 90Y-Labeled Somatostatin AnalogsStanislas Pauwels, Raffaella Barone, Stéphan Walrand, Françoise Borson-Chazot, Roelf Valkema, Larry K. Kvols, Eric P. Krenning and François JamarJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 92S-98S;
- You have accessPatient-Specific Dosimetry in Predicting Renal Toxicity with 90Y-DOTATOC: Relevance of Kidney Volume and Dose Rate in Finding a Dose–Effect RelationshipRaffaella Barone, Françoise Borson-Chazot, Roelf Valkema, Stéphan Walrand, Franck Chauvin, Lida Gogou, Larry K. Kvols, Eric P. Krenning, François Jamar and Stanislas PauwelsJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 99S-106S;
Jhanwar, Yuliya S.
- You have accessCurrent Status of Therapy of Solid TumorsYuliya S. Jhanwar and Chaitanya DivgiJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 141S-150S;
Jurcic, Joseph G.
- You have accessThe Promise of Targeted α-Particle TherapyDeborah A. Mulford, David A. Scheinberg and Joseph G. JurcicJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 199S-204S;
K
Kassis, Amin I.
- You have accessRadiobiologic Principles in Radionuclide TherapyAmin I. Kassis and S. James AdelsteinJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 4S-12S;
Kooij, Peter P.M.
- You have accessPeptide Receptor Radionuclide Therapy for Non-Radioiodine-Avid Differentiated Thyroid CarcinomaJaap J.M. Teunissen, Dik J. Kwekkeboom, Peter P.M. Kooij, Willem H. Bakker and Eric P. KrenningJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 107S-114S;
- You have accessLong-Term Follow-Up of Renal Function After Peptide Receptor Radiation Therapy with 90Y-DOTA0,Tyr3-Octreotide and 177Lu-DOTA0, Tyr3-OctreotateRoelf Valkema, Stanislas A. Pauwels, Larry K. Kvols, Dik J. Kwekkeboom, Francois Jamar, Marion de Jong, Raffaella Barone, Stephan Walrand, Peter P.M. Kooij, Willem H. Bakker, Janet Lasher and Eric P. KrenningJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 83S-91S;
Krenning, Eric P.
- You have accessPeptide Receptor Radionuclide Therapy for Non-Radioiodine-Avid Differentiated Thyroid CarcinomaJaap J.M. Teunissen, Dik J. Kwekkeboom, Peter P.M. Kooij, Willem H. Bakker and Eric P. KrenningJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 107S-114S;
- You have accessCombination Radionuclide Therapy Using 177Lu- and 90Y-Labeled Somatostatin AnalogsMarion de Jong, Wout A.P. Breeman, Roelf Valkema, Bert F. Bernard and Eric P. KrenningJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 13S-17S;
- You have accessInduction of Apoptosis with Hybrids of Arg-Gly-Asp Molecules and Peptides and Antimitotic Effects of Hybrids of Cytostatic Drugs and PeptidesLeo J. Hofland, Astrid Capello, Eric P. Krenning, Marion de Jong and Martin P. van HagenJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 191S-198S;
- You have accessA Pragmatic Perspective on Molecular Targeted Radionuclide TherapySteven M. Larson and Eric P. KrenningJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 1S-3S;
- You have accessOverview of Results of Peptide Receptor Radionuclide Therapy with 3 Radiolabeled Somatostatin AnalogsDik J. Kwekkeboom, Jan Mueller-Brand, Giovanni Paganelli, Lowell B. Anthony, Stanislas Pauwels, Larry K. Kvols, Thomas M. O’Dorisio, Roelf Valkema, Lisa Bodei, Marco Chinol, Helmut R. Maecke and Eric P. KrenningJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 62S-66S;
- You have accessCandidates for Peptide Receptor Radiotherapy Today and in the FutureJean Claude Reubi, Helmut R. Mäcke and Eric P. KrenningJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 67S-75S;
- You have accessMolecular Imaging as In Vivo Molecular Pathology for Gastroenteropancreatic Neuroendocrine Tumors: Implications for Follow-Up After TherapyEric P. Krenning, Roelf Valkema, Dik J. Kwekkeboom, Wouter W. de Herder, Casper H.J. van Eijck, Marion de Jong, Stanislas Pauwels and Jean-Claude ReubiJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 76S-82S;
- You have accessLong-Term Follow-Up of Renal Function After Peptide Receptor Radiation Therapy with 90Y-DOTA0,Tyr3-Octreotide and 177Lu-DOTA0, Tyr3-OctreotateRoelf Valkema, Stanislas A. Pauwels, Larry K. Kvols, Dik J. Kwekkeboom, Francois Jamar, Marion de Jong, Raffaella Barone, Stephan Walrand, Peter P.M. Kooij, Willem H. Bakker, Janet Lasher and Eric P. KrenningJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 83S-91S;
- You have accessPractical Dosimetry of Peptide Receptor Radionuclide Therapy with 90Y-Labeled Somatostatin AnalogsStanislas Pauwels, Raffaella Barone, Stéphan Walrand, Françoise Borson-Chazot, Roelf Valkema, Larry K. Kvols, Eric P. Krenning and François JamarJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 92S-98S;
- You have accessPatient-Specific Dosimetry in Predicting Renal Toxicity with 90Y-DOTATOC: Relevance of Kidney Volume and Dose Rate in Finding a Dose–Effect RelationshipRaffaella Barone, Françoise Borson-Chazot, Roelf Valkema, Stéphan Walrand, Franck Chauvin, Lida Gogou, Larry K. Kvols, Eric P. Krenning, François Jamar and Stanislas PauwelsJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 99S-106S;
Kvols, Larry K.
- You have accessRadiation Sensitizers: A Selective Review of Molecules Targeting DNA and non-DNA TargetsLarry K. KvolsJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 187S-190S;
- You have accessOverview of Results of Peptide Receptor Radionuclide Therapy with 3 Radiolabeled Somatostatin AnalogsDik J. Kwekkeboom, Jan Mueller-Brand, Giovanni Paganelli, Lowell B. Anthony, Stanislas Pauwels, Larry K. Kvols, Thomas M. O’Dorisio, Roelf Valkema, Lisa Bodei, Marco Chinol, Helmut R. Maecke and Eric P. KrenningJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 62S-66S;
- You have accessLong-Term Follow-Up of Renal Function After Peptide Receptor Radiation Therapy with 90Y-DOTA0,Tyr3-Octreotide and 177Lu-DOTA0, Tyr3-OctreotateRoelf Valkema, Stanislas A. Pauwels, Larry K. Kvols, Dik J. Kwekkeboom, Francois Jamar, Marion de Jong, Raffaella Barone, Stephan Walrand, Peter P.M. Kooij, Willem H. Bakker, Janet Lasher and Eric P. KrenningJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 83S-91S;
- You have accessPractical Dosimetry of Peptide Receptor Radionuclide Therapy with 90Y-Labeled Somatostatin AnalogsStanislas Pauwels, Raffaella Barone, Stéphan Walrand, Françoise Borson-Chazot, Roelf Valkema, Larry K. Kvols, Eric P. Krenning and François JamarJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 92S-98S;
- You have accessPatient-Specific Dosimetry in Predicting Renal Toxicity with 90Y-DOTATOC: Relevance of Kidney Volume and Dose Rate in Finding a Dose–Effect RelationshipRaffaella Barone, Françoise Borson-Chazot, Roelf Valkema, Stéphan Walrand, Franck Chauvin, Lida Gogou, Larry K. Kvols, Eric P. Krenning, François Jamar and Stanislas PauwelsJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 99S-106S;
Kwekkeboom, Dik J.
- You have accessPeptide Receptor Radionuclide Therapy for Non-Radioiodine-Avid Differentiated Thyroid CarcinomaJaap J.M. Teunissen, Dik J. Kwekkeboom, Peter P.M. Kooij, Willem H. Bakker and Eric P. KrenningJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 107S-114S;
- You have accessOverview of Results of Peptide Receptor Radionuclide Therapy with 3 Radiolabeled Somatostatin AnalogsDik J. Kwekkeboom, Jan Mueller-Brand, Giovanni Paganelli, Lowell B. Anthony, Stanislas Pauwels, Larry K. Kvols, Thomas M. O’Dorisio, Roelf Valkema, Lisa Bodei, Marco Chinol, Helmut R. Maecke and Eric P. KrenningJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 62S-66S;
- You have accessMolecular Imaging as In Vivo Molecular Pathology for Gastroenteropancreatic Neuroendocrine Tumors: Implications for Follow-Up After TherapyEric P. Krenning, Roelf Valkema, Dik J. Kwekkeboom, Wouter W. de Herder, Casper H.J. van Eijck, Marion de Jong, Stanislas Pauwels and Jean-Claude ReubiJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 76S-82S;
- You have accessLong-Term Follow-Up of Renal Function After Peptide Receptor Radiation Therapy with 90Y-DOTA0,Tyr3-Octreotide and 177Lu-DOTA0, Tyr3-OctreotateRoelf Valkema, Stanislas A. Pauwels, Larry K. Kvols, Dik J. Kwekkeboom, Francois Jamar, Marion de Jong, Raffaella Barone, Stephan Walrand, Peter P.M. Kooij, Willem H. Bakker, Janet Lasher and Eric P. KrenningJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 83S-91S;
L
Larson, Steven M.
- You have accessA Pragmatic Perspective on Molecular Targeted Radionuclide TherapySteven M. Larson and Eric P. KrenningJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 1S-3S;
Lasher, Janet
- You have accessLong-Term Follow-Up of Renal Function After Peptide Receptor Radiation Therapy with 90Y-DOTA0,Tyr3-Octreotide and 177Lu-DOTA0, Tyr3-OctreotateRoelf Valkema, Stanislas A. Pauwels, Larry K. Kvols, Dik J. Kwekkeboom, Francois Jamar, Marion de Jong, Raffaella Barone, Stephan Walrand, Peter P.M. Kooij, Willem H. Bakker, Janet Lasher and Eric P. KrenningJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 83S-91S;
Lewington, Val J.
- You have accessBone-Seeking Radionuclides For TherapyVal J. LewingtonJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 38S-47S;
M
Mäcke, Helmut R.
- You have accessCandidates for Peptide Receptor Radiotherapy Today and in the FutureJean Claude Reubi, Helmut R. Mäcke and Eric P. KrenningJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 67S-75S;
Maecke, Helmut R.
- You have access68Ga-Labeled Peptides in Tumor ImagingHelmut R. Maecke, Michael Hofmann and Uwe HaberkornJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 172S-178S;
- You have accessOverview of Results of Peptide Receptor Radionuclide Therapy with 3 Radiolabeled Somatostatin AnalogsDik J. Kwekkeboom, Jan Mueller-Brand, Giovanni Paganelli, Lowell B. Anthony, Stanislas Pauwels, Larry K. Kvols, Thomas M. O’Dorisio, Roelf Valkema, Lisa Bodei, Marco Chinol, Helmut R. Maecke and Eric P. KrenningJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 62S-66S;
Menda, Yusuf
- You have accessMIBG and Somatostatin Receptor Analogs in Children: Current Concepts on Diagnostic and Therapeutic UseFarzana D. Pashankar, M. Sue O’Dorisio and Yusuf MendaJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 55S-61S;
Modak, Shakeel
- You have accessAntibody-Based Targeted Radiation to Pediatric TumorsShakeel Modak and Nai-Kong V. CheungJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 157S-163S;
Mueller-Brand, Jan
- You have accessOverview of Results of Peptide Receptor Radionuclide Therapy with 3 Radiolabeled Somatostatin AnalogsDik J. Kwekkeboom, Jan Mueller-Brand, Giovanni Paganelli, Lowell B. Anthony, Stanislas Pauwels, Larry K. Kvols, Thomas M. O’Dorisio, Roelf Valkema, Lisa Bodei, Marco Chinol, Helmut R. Maecke and Eric P. KrenningJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 62S-66S;
Mulford, Deborah A.
- You have accessThe Promise of Targeted α-Particle TherapyDeborah A. Mulford, David A. Scheinberg and Joseph G. JurcicJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 199S-204S;
O
O’Dorisio, M. Sue
- You have accessMIBG and Somatostatin Receptor Analogs in Children: Current Concepts on Diagnostic and Therapeutic UseFarzana D. Pashankar, M. Sue O’Dorisio and Yusuf MendaJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 55S-61S;
O’Dorisio, Thomas M.
- You have accessOverview of Results of Peptide Receptor Radionuclide Therapy with 3 Radiolabeled Somatostatin AnalogsDik J. Kwekkeboom, Jan Mueller-Brand, Giovanni Paganelli, Lowell B. Anthony, Stanislas Pauwels, Larry K. Kvols, Thomas M. O’Dorisio, Roelf Valkema, Lisa Bodei, Marco Chinol, Helmut R. Maecke and Eric P. KrenningJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 62S-66S;
P
Paganelli, Giovanni
- You have accessOverview of Results of Peptide Receptor Radionuclide Therapy with 3 Radiolabeled Somatostatin AnalogsDik J. Kwekkeboom, Jan Mueller-Brand, Giovanni Paganelli, Lowell B. Anthony, Stanislas Pauwels, Larry K. Kvols, Thomas M. O’Dorisio, Roelf Valkema, Lisa Bodei, Marco Chinol, Helmut R. Maecke and Eric P. KrenningJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 62S-66S;
Pashankar, Farzana D.
- You have accessMIBG and Somatostatin Receptor Analogs in Children: Current Concepts on Diagnostic and Therapeutic UseFarzana D. Pashankar, M. Sue O’Dorisio and Yusuf MendaJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 55S-61S;
Pauwels, Stanislas
- You have accessOverview of Results of Peptide Receptor Radionuclide Therapy with 3 Radiolabeled Somatostatin AnalogsDik J. Kwekkeboom, Jan Mueller-Brand, Giovanni Paganelli, Lowell B. Anthony, Stanislas Pauwels, Larry K. Kvols, Thomas M. O’Dorisio, Roelf Valkema, Lisa Bodei, Marco Chinol, Helmut R. Maecke and Eric P. KrenningJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 62S-66S;
- You have accessMolecular Imaging as In Vivo Molecular Pathology for Gastroenteropancreatic Neuroendocrine Tumors: Implications for Follow-Up After TherapyEric P. Krenning, Roelf Valkema, Dik J. Kwekkeboom, Wouter W. de Herder, Casper H.J. van Eijck, Marion de Jong, Stanislas Pauwels and Jean-Claude ReubiJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 76S-82S;
- You have accessPractical Dosimetry of Peptide Receptor Radionuclide Therapy with 90Y-Labeled Somatostatin AnalogsStanislas Pauwels, Raffaella Barone, Stéphan Walrand, Françoise Borson-Chazot, Roelf Valkema, Larry K. Kvols, Eric P. Krenning and François JamarJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 92S-98S;
- You have accessPatient-Specific Dosimetry in Predicting Renal Toxicity with 90Y-DOTATOC: Relevance of Kidney Volume and Dose Rate in Finding a Dose–Effect RelationshipRaffaella Barone, Françoise Borson-Chazot, Roelf Valkema, Stéphan Walrand, Franck Chauvin, Lida Gogou, Larry K. Kvols, Eric P. Krenning, François Jamar and Stanislas PauwelsJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 99S-106S;
Pauwels, Stanislas A.
- You have accessLong-Term Follow-Up of Renal Function After Peptide Receptor Radiation Therapy with 90Y-DOTA0,Tyr3-Octreotide and 177Lu-DOTA0, Tyr3-OctreotateRoelf Valkema, Stanislas A. Pauwels, Larry K. Kvols, Dik J. Kwekkeboom, Francois Jamar, Marion de Jong, Raffaella Barone, Stephan Walrand, Peter P.M. Kooij, Willem H. Bakker, Janet Lasher and Eric P. KrenningJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 83S-91S;
R
Reiners, Christoph
- You have accessRadiosynovectomy in Rheumatology, Orthopedics, and HemophiliaPeter Schneider, Jamshid Farahati and Christoph ReinersJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 48S-54S;
Reubi, Jean-Claude
- You have accessMolecular Imaging as In Vivo Molecular Pathology for Gastroenteropancreatic Neuroendocrine Tumors: Implications for Follow-Up After TherapyEric P. Krenning, Roelf Valkema, Dik J. Kwekkeboom, Wouter W. de Herder, Casper H.J. van Eijck, Marion de Jong, Stanislas Pauwels and Jean-Claude ReubiJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 76S-82S;
Reubi, Jean Claude
- You have accessCandidates for Peptide Receptor Radiotherapy Today and in the FutureJean Claude Reubi, Helmut R. Mäcke and Eric P. KrenningJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 67S-75S;
Robbins, Richard J.
- You have accessThe Evolving Role of 131I for the Treatment of Differentiated Thyroid CarcinomaRichard J. Robbins and Martin J. SchlumbergerJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 28S-37S;
S
Scheinberg, David A.
- You have accessThe Promise of Targeted α-Particle TherapyDeborah A. Mulford, David A. Scheinberg and Joseph G. JurcicJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 199S-204S;
Schlumberger, Martin J.
- You have accessThe Evolving Role of 131I for the Treatment of Differentiated Thyroid CarcinomaRichard J. Robbins and Martin J. SchlumbergerJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 28S-37S;
Schneider, Peter
- You have accessRadiosynovectomy in Rheumatology, Orthopedics, and HemophiliaPeter Schneider, Jamshid Farahati and Christoph ReinersJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 48S-54S;
Sgouros, George
- You have accessDosimetry of Internal EmittersGeorge SgourosJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 18S-27S;
Sharkey, Robert M.
- You have accessPerspectives on Cancer Therapy with Radiolabeled Monoclonal AntibodiesRobert M. Sharkey and David M. GoldenbergJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 115S-127S;
T
Teunissen, Jaap J.M.
- You have accessPeptide Receptor Radionuclide Therapy for Non-Radioiodine-Avid Differentiated Thyroid CarcinomaJaap J.M. Teunissen, Dik J. Kwekkeboom, Peter P.M. Kooij, Willem H. Bakker and Eric P. KrenningJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 107S-114S;
V
Valkema, Roelf
- You have accessCombination Radionuclide Therapy Using 177Lu- and 90Y-Labeled Somatostatin AnalogsMarion de Jong, Wout A.P. Breeman, Roelf Valkema, Bert F. Bernard and Eric P. KrenningJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 13S-17S;
- You have accessOverview of Results of Peptide Receptor Radionuclide Therapy with 3 Radiolabeled Somatostatin AnalogsDik J. Kwekkeboom, Jan Mueller-Brand, Giovanni Paganelli, Lowell B. Anthony, Stanislas Pauwels, Larry K. Kvols, Thomas M. O’Dorisio, Roelf Valkema, Lisa Bodei, Marco Chinol, Helmut R. Maecke and Eric P. KrenningJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 62S-66S;
- You have accessMolecular Imaging as In Vivo Molecular Pathology for Gastroenteropancreatic Neuroendocrine Tumors: Implications for Follow-Up After TherapyEric P. Krenning, Roelf Valkema, Dik J. Kwekkeboom, Wouter W. de Herder, Casper H.J. van Eijck, Marion de Jong, Stanislas Pauwels and Jean-Claude ReubiJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 76S-82S;
- You have accessLong-Term Follow-Up of Renal Function After Peptide Receptor Radiation Therapy with 90Y-DOTA0,Tyr3-Octreotide and 177Lu-DOTA0, Tyr3-OctreotateRoelf Valkema, Stanislas A. Pauwels, Larry K. Kvols, Dik J. Kwekkeboom, Francois Jamar, Marion de Jong, Raffaella Barone, Stephan Walrand, Peter P.M. Kooij, Willem H. Bakker, Janet Lasher and Eric P. KrenningJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 83S-91S;
- You have accessPractical Dosimetry of Peptide Receptor Radionuclide Therapy with 90Y-Labeled Somatostatin AnalogsStanislas Pauwels, Raffaella Barone, Stéphan Walrand, Françoise Borson-Chazot, Roelf Valkema, Larry K. Kvols, Eric P. Krenning and François JamarJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 92S-98S;
- You have accessPatient-Specific Dosimetry in Predicting Renal Toxicity with 90Y-DOTATOC: Relevance of Kidney Volume and Dose Rate in Finding a Dose–Effect RelationshipRaffaella Barone, Françoise Borson-Chazot, Roelf Valkema, Stéphan Walrand, Franck Chauvin, Lida Gogou, Larry K. Kvols, Eric P. Krenning, François Jamar and Stanislas PauwelsJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 99S-106S;
van Dongen, Guus A.
- You have accessThe Promise of Immuno-PET in RadioimmunotherapyIris Verel, Gerard W.M. Visser and Guus A. van DongenJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 164S-171S;
van Eijck, Casper H.J.
- You have accessMolecular Imaging as In Vivo Molecular Pathology for Gastroenteropancreatic Neuroendocrine Tumors: Implications for Follow-Up After TherapyEric P. Krenning, Roelf Valkema, Dik J. Kwekkeboom, Wouter W. de Herder, Casper H.J. van Eijck, Marion de Jong, Stanislas Pauwels and Jean-Claude ReubiJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 76S-82S;
van Hagen, Martin P.
- You have accessInduction of Apoptosis with Hybrids of Arg-Gly-Asp Molecules and Peptides and Antimitotic Effects of Hybrids of Cytostatic Drugs and PeptidesLeo J. Hofland, Astrid Capello, Eric P. Krenning, Marion de Jong and Martin P. van HagenJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 191S-198S;
Verel, Iris
- You have accessThe Promise of Immuno-PET in RadioimmunotherapyIris Verel, Gerard W.M. Visser and Guus A. van DongenJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 164S-171S;
Visser, Gerard W.M.
- You have accessThe Promise of Immuno-PET in RadioimmunotherapyIris Verel, Gerard W.M. Visser and Guus A. van DongenJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 164S-171S;
W
Wahl, Richard L.
- You have accessTositumomab and 131I Therapy in Non-Hodgkin’s LymphomaRichard L. WahlJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 128S-140S;
Walrand, Stephan
- You have accessLong-Term Follow-Up of Renal Function After Peptide Receptor Radiation Therapy with 90Y-DOTA0,Tyr3-Octreotide and 177Lu-DOTA0, Tyr3-OctreotateRoelf Valkema, Stanislas A. Pauwels, Larry K. Kvols, Dik J. Kwekkeboom, Francois Jamar, Marion de Jong, Raffaella Barone, Stephan Walrand, Peter P.M. Kooij, Willem H. Bakker, Janet Lasher and Eric P. KrenningJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 83S-91S;
Walrand, Stéphan
- You have accessPractical Dosimetry of Peptide Receptor Radionuclide Therapy with 90Y-Labeled Somatostatin AnalogsStanislas Pauwels, Raffaella Barone, Stéphan Walrand, Françoise Borson-Chazot, Roelf Valkema, Larry K. Kvols, Eric P. Krenning and François JamarJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 92S-98S;
- You have accessPatient-Specific Dosimetry in Predicting Renal Toxicity with 90Y-DOTATOC: Relevance of Kidney Volume and Dose Rate in Finding a Dose–Effect RelationshipRaffaella Barone, Françoise Borson-Chazot, Roelf Valkema, Stéphan Walrand, Franck Chauvin, Lida Gogou, Larry K. Kvols, Eric P. Krenning, François Jamar and Stanislas PauwelsJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 99S-106S;
Z
Zalutsky, Michael R.
- You have accessCurrent Status of Therapy of Solid Tumors: Brain Tumor TherapyMichael R. ZalutskyJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 151S-156S;
Zinn, Kurt R.
- You have accessRadiotargeted Gene TherapyDonald J. Buchsbaum, Tandra R. Chaudhuri and Kurt R. ZinnJournal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 179S-186S;